Phase IIa trial of inhaled sodium nitrite (AIR 001) in patients with heart failure with preserved ejection fraction.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Apr 2017
At a glance
- Drugs Sodium nitrite (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 07 Jan 2016 Top-line data expected by this month, as per Mast Therapeutics media release.
- 07 Jan 2016 Status changed from recruiting to active, no longer recruiting, as per Mast Therapeutics media release.
- 09 Feb 2015 New trial record